Andrew Frazer & Amanda Weiss, Gene Therapy Manufacturing | Sounds of Science Podcast: E63

Gene therapy is still in its early stages. Since the field is new but booming, the issue of manufacturing has become more crucial. How do we make these tricky products at a scale large enough to help patients without a longstanding infrastructure? Joining me to discuss this issue is Charles River Associate Director of Gene Therapy, Andrew Frazer, and Purespring Therapeutics' VP of Chemistry, Manufacturing and Controls, Amanda Weiss.